Characterization of bovine viral diarrhea virus (BVDV) types 1 and 2 isolates for use in vaccines;Caracterização de amostras atenuadas do vírus da diarréia viral bovina (BVDV) tipos 1 e 2 para uso em vacinas

Pesquisa Veterinaria Brasileira

Volumn 24, Issue 1, 2004, Pages 35-42

  De Lima, Marcelo ^a   Furtado Flores, Eduardo ^a,b   Weiblen, Rudi ^a,c   Flores Vogel, Fernanda Silveira ^c   Arenhart, Sandra ^c  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b Bolsista CNPq   (Brazil)

^c Medicina Veterinária ^*

Author keywords

Attenuation; Bovine viral diarrhea virus (BVDV); Modified live vaccine

Indexed keywords

MONOCLONAL ANTIBODY; NYSTATIN; PENICILLIN G; STREPTOMYCIN; VIRUS VACCINE;

ANTIGEN BINDING; ANTIGENICITY; ARTICLE; ATTENUATION; BOVINE DIARRHEA VIRUS; CONTROLLED STUDY; INOCULATION; LEUKOCYTE; MOLECULAR CLONING; NONHUMAN; NOSE SECRETION; PHENOTYPE; SEROCONVERSION; SEROLOGY; TISSUE CULTURE; ULTRAVIOLET RADIATION; VACCINATION; VIROGENESIS; VIRUS DETECTION; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS MORPHOLOGY; VIRUS PLAQUE; VIRUS STRAIN; VIRUS TITRATION;

ANIMALIA; BOVINAE; BOVINE VIRAL DIARRHEA VIRUS 1; BOVINE VIRAL DIARRHEA VIRUS 2;

EID: 2442532584     PISSN: 0100736X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0100-736x2004000100009     Document Type: Article

References (31)

1. Baker J.C. 1995. The clinical manifestations of bovine viral diarrhea infection. Vet. Clin. North Am. 11(3):425-446.
2. Beer M., Hehnen H.R., Wolfmeyer A., Poll G., Kaaden O.R. & Wolf G. 2000. A new inactivated BVDV genotype I and II vaccine. An immunization and challenge study with BVDV genotype I. Vet. Microbiol. 77:195-208.
3. Bolin S., Moenning V., Kelso Gourley N.E. & Ridpath J. 1988. Monoclonal antibodies with neutralizing activity segregate isolates of bovine viral diarrhea virus into groups. Arch. Virol. 99:117-123.
4. Botton S. A., Silva A.M., Brum M.C.S., Weiblen R. & Flores E.F. 1998. Antigenic characterization of Brazilian bovine viral diarrhea virus isolates by monoclonal antibodies and cross-neutralization. Braz. J. Med. Biol. Res. 31(11):1429-1438.
5. Brum M.C.S., Weiblen R., Flores F.F., Pituco E.M., Tobias F.L. & Winkelmann E.R. 2002. Proteção fetal frente a desafio com o vírus da Diarréia Viral Bovina (BVDV) em ovelhas imunizadas com duas amostras de vírus modificadas experimentalmente. Pesq. Vet. Bras. 22 (2):64-72.
6. Bruschke C.J.M., van Oirschot J.T. & van Rijn P.A. 1999. An experimental multivalent bovine virus diarrhea virus E2 subunit vaccines and two experimental conventionally inactivated vaccines induce partial fetal protection in sheep. Vaccine 17:1983-1991.
7. Corapi W.V., Donis R.O. & Dubovi E.J. 1990. Characterization of a panel of monoclonal antibodies and their use in the study of the antigenic diversity of bovine viral diarrhea virus. Am. J. Vet. Res. 51(9):1388-1394.
8. Cortese V.S., Grooms D.L., Ellis J., Bolin S.R., Ridpath J. & Brock K.V. 1998a. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine. Am. J. Vet. Res. 59(11):1409-1413.
9. Cortese V.S., Whittaker R., Ellis J., Ridpath J.F. & Bolin S.R. 1998b. Specificity and duration of neutralizing antibodies induced in healthy cattle after administration of a modified-live vírus vaccine against bovine viral diarrhea. Am. J. Vet. Res.. 59(7):848-850.
10. Deregt D., van Rijn P.A., Wiens T.Y. & van den Hurk J. 1998. Monoclonal antibodies to the E2 protein of a new genotype (type 2) of bovine viral diarrhea virus define three antigenic domains involved in neutralization. Virus Res. 57:171-181.
11. Donis R.O. 1995. Molecular biology of bovine viral diarrhea virus and its interactions with the host. Vet. Clin. North Am. 11(3):393-423.
12. Flores E.F., Ridpath J., Weiblen R., Vogel F.S.F. & Gil L.H.V.G. 2002. Phylogenetic analysis of Brazilian bovine viral diarrhea virus type 2 (BVDV-2) isolates: evidence for a subgenotype within BVDV-2. Virus Res. 87:51-60.
13. Frey H.R., Eicken K., Grummer B., Kenklies S., Oguzoglu T.C. & Moenning V. 2002. Foetal protection against bovine viral diarrhea virus after two-step vaccination. J. Vet. Med. B 49 (10):489-493.
14. Fulton R.W. & Burge L.J. 2001. Bovine viral diarrhea virus types 1 and 2 antibody response in calves receiving modified live virus or inactivated vaccines. Vaccine 19:264-274.
15. Fulton R.W., Ridpath J.F., Confer A.W., Saliki J.T., Burgue L.J. & Payton M.E. 2003a. Bovine viral diarrhoea virus antigenic diversity: impact on disease and vaccination programmes. Biologicals 31(2):89-95.
16. Fulton R.W., Saliki J.T., Burge L.J. & Payton M.E. 2003b. Humoral immune response and assessment of vaccine virus shedding in calves receiving modified live virus vaccines containing bovine herpesvirus-1 and bovine viral diarrhea virus 1a. J. Vet. Med. 50:31-37.
17. Hamers C., Di Valentin E., Lecomte C., Lambot M., Joris E., Genicot B. & Pastoret P.P. 2002. Virus neutralizing antibodies against 22 bovine viral diarrhoea virus isolates in vaccinated calves. Vet. J. 163:61-67.
18. Houe H. 2003. Economic inpact of BVDV infections in dairies. Biologicals 31(2)137-143.
19. Kreutz L.C., Donis R., Gil L.H.V.G., Lima M., Hoffman A.N., Garcez D.C.P., Flores E.F. & Weiblen R. 2000. Production and characterization of monoclonal antibodies to Brazilian isolates of bovine viral diarrhea virus. Braz. J. Med. Biol. Res. 33(12):1459-1466.
20. Lindenbach B.D. & Rice C.M. 2001. Flaviviridae: the viruses and their replication. Cap.32, p.991-1042. In: Knipe D.M. & Howley P.M. (ed.) Fields Virology. Lippincot Williams & Wilkins, Philadelphia.
21. Oirschot J.T. van, Bruschke C.J.M. & Rijn P.A. van 1999. Vaccination of cattle against bovine viral diarrhoea. Vet. Microbiol. 64:169-183.
22. Oliveira L.G., Oliveira E.A.S. & Silva L.H.T. 1996. Presença de pestivírus e anticorpos contra pestivírus em soros e cultivos celulares. Arq. Bras. Med Vet. Zootec. 48:513-521.
23. Reed L. & Müench H.A. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 18:493-494.
24. Ridpath J.F., Bolin S. & Dubovi E. 1994. Segregation of bovine viral diarrhea virus into genotypes. Virology 205:66-74.
25. Ridapth J.F. & Bolin S.R. 1995. Delayed onset postvaccinal mucosal disease as a result of genetic recombination between genotype 1 and genotype 2 BVDV. Virology 212:259-262.
26. Ridpath J.F. 2003a. BVDV genotypes and biotypes: practical implications for diagnosis and control. Biologicals 31:127-131.
27. Ridpath J.F. 2003b. Introduction to detecting and controlling BVDV infections. Biologicals 31(2):87.
28. Scherer C.F.C., Flores E.F., Weiblen R., Caron L., Irigoyen L.F., Neves J.P. & Maciel M.N. 2001. Experimental infection of pregnant ewes with bovine viral diarrhea virus type-2 (BVDV-2): effects on the pregnancy and fetus. Vet. Microbiol. 77:285-299.
29. Thrusfield M. 1986. Veterinary Epidemiology. Chap.16: Serological epidemiology. Butterworth, London, p.175-185.
30. Vilcek S., Paton D.J., Durkovic B., Strojny L., Ibata G., Moussa A., Loitsch A., Rossmanith W., Veja S., Scicluna M.T. & Paif V. 2001.. Bovine viral diarrhea virus genotype 1 can be separated into at least eleven genetic groups. Arch. Virol. 146(1):99-115.
31. Zimmer G.M., Wentink G.H., Bruschke C., Westenbrink, F.J., Brinkhof J. & de Goey I. 2002. Failure of foetal protection after vaccination against an experimental infection with bovine virus diarrhea virus. Vet. Microbiol. 89:255-265.